CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Anuh Pharma Ltd.

NSE : ANUHPHREQ BSE : 506260 ISIN CODE : INE489G01022Industry : Pharmaceuticals

News

  • Anuh Pharma - Updates 06 Mar 2026 | 18:27 | Dion Global

    Anuh Pharma Limited has informed the Exchange regarding Completion Of European Directorate For The Quality Of Medicines & Healthcare (EDQM) Audit And...more...

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Completion Of European Directorate For The Quality Of Medicines & Hea 06 Mar 2026 | 18:22 | Dion Global

    Completion of European Directorate for the Quality of Medicines & Healthcare (EDQM) Audit and our facilities were found compliant under the Auditmore...

  • Anuh Pharma - Copy of Newspaper Publication 18 Feb 2026 | 16:34 | Dion Global

    Anuh Pharma Limited has informed the Exchange about Newspaper Publication regarding notice to shareholders for Special Window for transfer and demate...more...

  • Anuh Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation 13 Feb 2026 | 16:26 | Dion Global

    Investor Presentation for Q3 FY 2025-26more...

  • Anuh Pharma - Investor Presentation 13 Feb 2026 | 16:22 | Dion Global

    Anuh Pharma Limited has informed the Exchange about Investor Presentationmore...

  • Anuh Pharma - Copy of Newspaper Publication 08 Feb 2026 | 17:06 | Dion Global

    Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Un-Audited financial results for the Quarter ended ...more...

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Completion Of United States Food And Drug Administration (USFDA) Insp 06 Feb 2026 | 19:47 | Dion Global

    Completion of United States Food and Drug Administration (USFDA) Inspection with no Form 483 observations issued.more...

  • Anuh Pharma - Updates 06 Feb 2026 | 19:40 | Dion Global

    Anuh Pharma Limited has informed the Exchange regarding Completion of United States Food and Drug Administration (USFDA) inspection with no ...more...

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Granting Authorization To Key Managerial Personnel For Determination 06 Feb 2026 | 19:30 | Dion Global

    Granting Authorization to Key Managerial Personnel for determination of materiality of events/ information under Regulation 30 (5) of SEBI (LODR) Reg...more...

  • Anuh Pharma - Updates 06 Feb 2026 | 19:23 | Dion Global

    Anuh Pharma Limited has informed the Exchange regarding Granting Authorization to Key Managerial Personnel for determination of materiality ...more...

  • Anuh Pharma Q3 net profit up 30.08% at Rs 13.45 cr 06 Feb 2026 | 19:10 | Dion Global

    The company reported standalone net profit of Rs 13.45 crore for the quarter ended December 31 2025 as compared to Rs 10.34 crore in the same period ...more...

  • Anuh Pharma - Results-Financial Results For December 31, 2025 06 Feb 2026 | 19:03 | Dion Global

    Unaudited Financial Results for the quarter ended 31st December 2025more...

  • Anuh Pharma - Outcome of Board Meeting 06 Feb 2026 | 18:49 | Dion Global

    Anuh Pharma Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...

  • Anuh Pharma - Outcome of Board Meeting 06 Feb 2026 | 18:29 | Dion Global

    Anuh Pharma Limited has informed the Exchange regarding the approval of Un-audited Financial Results for the quarter ended December 31 2025 ...more...

  • Anuh Pharma - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31 02 Feb 2026 | 15:51 | Dion Global

    Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and appro...more...

  • Anuh Pharma Ltd - Action(s) taken or orders passed 21 Jan 2026 | 15:44 | Dion Global

    Anuh Pharma Limited has informed the Exchange about orders passed regarding Assessment Order received under Section 143(3) read with Section...more...

  • Anuh Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025 20 Jan 2026 | 16:40 | Dion Global

    As of December 2025 71.82% is owned by Promoters and 28.18% by Public. Among Promoters holding Indian Promoters holds 71.80% and Foreign Promoters ho...more...

  • Anuh Pharma Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018 12 Jan 2026 | 15:42 | Dion Global

    Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • Anuh Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 12 Jan 2026 | 15:33 | Dion Global

    Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2025...more...

  • Anuh Pharma Ltd - Trading Window 25 Dec 2025 | 14:27 | Dion Global

    Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex74563.92-1.93%
NSE Index23151.1-2.06%
B500DIVL503456.14-2.58%
BSE 1000 9930.73-2.32%
BSE 100LCTMC8618.83-2.15%
BSE Auto 53876.79-3.27%

Commodity

Gold158013-1.12%
Silver260297-3.09%
Copper1230.5201.74%
Crude Oil884137.86%
Lead19444.35%
Mentha Oil1060.7-0.63%
Nickel1637.3113.50%

Currency

USD/INR 92.35(0.46 %)
GBP/INR 123.47(-0.13 %)
EUR/INR 106.62(-0.31 %)
JPY/INR 0.58(-0.36 %)
CAD/INR 67.91(0.49 %)
HKD/INR 11.80(0.44 %)